secwatch.observer — SEC 8-K summary
======================================

Issuer:     GOLDENWELL BIOTECH, INC. (GWLL)
CIK:        0001800373
Form:       8-K
Filed at:   2026-10-09T13:50:45+00:00
Accession:  0001477932-26-006138
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Goldenwell Biotech adds Ming Zhou to board; CEO Shuang Liu gifts her 20.2% stake
--------------------------------------------------------------------------------

- Board appointed Ming Zhou, 57, as a director on October 8, 2026; board now has four members: Shuang Liu, Yang Lee, Hua Xie and Zhou.
- CEO Shuang Liu gifted 20,000,000 shares to Zhou the same day, equal to roughly 20.2% of Goldenwell's issued and outstanding common stock.
- Zhou has been Managing Director of Get Health Co., Ltd. and Get Intertrading Co., Ltd. in Samutprakan, Thailand since 2021, covering health products, supplements and direct sales.
- Zhou attended China Central Radio and TV University (now Open University of China) from 1991 to 1993, earning an Associate's Degree in Business Administration.
- Company states no family relationships between Zhou and any director or officer, and no related-party transactions involving her since the start of the last fiscal year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/0001477932-26-006138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1800373/000147793226006138/gdwl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-006138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer